Credit Suisse Ag Talaris Therapeutics, Inc. Transaction History

Credit Suisse Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.94 - $1.64 $121 - $211	-129 Reduced 99.23%	1 $0
Q3 2022 Nov 10, 2022	BUY	$2.3 - $5.03 $248 - $543	108 Added 490.91%	130 $0
Q2 2022 Aug 12, 2022	BUY	$4.51 - $9.85 $99 - $216	22 New	22 $0

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.